rs483352911
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_005984.5(SLC25A1):c.517_526delCGGGAACAAG(p.Arg173fs) variant causes a frameshift, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,613,798 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000014 ( 0 hom. )
Consequence
SLC25A1
NM_005984.5 frameshift, splice_region
NM_005984.5 frameshift, splice_region
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 9.84
Genes affected
SLC25A1 (HGNC:10979): (solute carrier family 25 member 1) This gene encodes a member of the mitochondrial carrier subfamily of solute carrier proteins. Members of this family include nuclear-encoded transporters that translocate small metabolites across the mitochondrial membrane. This protein regulates the movement of citrate across the inner membranes of the mitochondria. Mutations in this gene have been associated with combined D-2- and L-2-hydroxyglutaric aciduria. Pseudogenes of this gene have been identified on chromosomes 7, 11, 16, and 19. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 22-19177119-CCTTGTTCCCG-C is Pathogenic according to our data. Variant chr22-19177119-CCTTGTTCCCG-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 42198.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-19177119-CCTTGTTCCCG-C is described in Lovd as [Pathogenic]. Variant chr22-19177119-CCTTGTTCCCG-C is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC25A1 | NM_005984.5 | c.517_526delCGGGAACAAG | p.Arg173fs | frameshift_variant, splice_region_variant | 5/9 | ENST00000215882.10 | NP_005975.1 | |
SLC25A1 | NM_001256534.2 | c.538_547delCGGGAACAAG | p.Arg180fs | frameshift_variant, splice_region_variant | 4/8 | NP_001243463.1 | ||
SLC25A1 | NM_001287387.2 | c.208_217delCGGGAACAAG | p.Arg70fs | frameshift_variant, splice_region_variant | 5/9 | NP_001274316.1 | ||
SLC25A1 | NR_046298.3 | n.441_450delCGGGAACAAG | splice_region_variant, non_coding_transcript_exon_variant | 4/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC25A1 | ENST00000215882.10 | c.517_526delCGGGAACAAG | p.Arg173fs | frameshift_variant, splice_region_variant | 5/9 | 1 | NM_005984.5 | ENSP00000215882.5 | ||
SLC25A1 | ENST00000451283.5 | c.208_217delCGGGAACAAG | p.Arg70fs | frameshift_variant, splice_region_variant | 5/9 | 2 | ENSP00000401480.1 | |||
SLC25A1 | ENST00000461267.1 | n.663_672delCGGGAACAAG | splice_region_variant, non_coding_transcript_exon_variant | 4/6 | 3 | |||||
SLC25A1 | ENST00000470922.5 | n.659_668delCGGGAACAAG | splice_region_variant, non_coding_transcript_exon_variant | 4/8 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152174Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
4
AN:
152174
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 251292Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135816
GnomAD3 exomes
AF:
AC:
7
AN:
251292
Hom.:
AF XY:
AC XY:
4
AN XY:
135816
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461624Hom.: 0 AF XY: 0.0000138 AC XY: 10AN XY: 727094
GnomAD4 exome
AF:
AC:
20
AN:
1461624
Hom.:
AF XY:
AC XY:
10
AN XY:
727094
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152174Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74344
GnomAD4 genome
AF:
AC:
4
AN:
152174
Hom.:
Cov.:
33
AF XY:
AC XY:
2
AN XY:
74344
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 25, 2021 | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 42198). This premature translational stop signal has been observed in individuals with D,L-2-hydroxyglutaric aciduria (PMID: 23561848, 29238895). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This sequence change creates a premature translational stop signal (p.Arg173Glyfs*2) in the SLC25A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC25A1 are known to be pathogenic (PMID: 23561848). - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen | Oct 23, 2020 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 01, 2023 | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 32340404, 29238895, 23561848) - |
2-hydroxyglutaric aciduria Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Centre for Mendelian Genomics, University Medical Centre Ljubljana | Aug 23, 2019 | This variant was classified as: Likely pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PM2. - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Apr 18, 2019 | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. This variant has been previously reported as disease-causing [PMID 23561848] - |
D,L-2-hydroxyglutaric aciduria Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | MGZ Medical Genetics Center | Dec 15, 2021 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 04, 2013 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at